Skip to content

Efficacy of Physical Activity Program in Metabolic-syndrome Females With Behcet Disease

Efficacy of Physical Activity Program in Metabolic-syndrome Females With Behcet Disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07702123
Enrollment
40
Registered
2026-07-14
Start date
2026-06-02
Completion date
2026-09-14
Last updated
2026-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behcet Disease, Metabolic Syndrome

Brief summary

metabolci syndrom is highly prevalent in behcet disorder females. usually physical activity is recommended to solve this problem

Detailed description

metabolci syndrom-fenales with behcet disorder (n=40) were assigned to group I or group II. Group I will perform treadmill walk for 40 minutes. group II will act as waitlist. the group will contian 20 females

Interventions

metabolci syndrom-females with behcet disorder assigned to group I (n=20) will perform treadmill walk for 40 minutes, thrice weekly, for 12 weeks

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* females with metabolci syndrome * females with behcet disorder

Exclusion criteria

* psychatric diseases women * mental diseased women

Design outcomes

Primary

MeasureTime frameDescription
high density lipoprotinit will be asessed after 12 weeksit is a lipid profile component

Secondary

MeasureTime frameDescription
triglycridesIt will be assessed after 12 weeksit is a lipid profile component
body mass indexIt will be assessed after 12 weeksit will be assessed on empty stomach
waist circumfrenceIt will be assessed after 12 weeksit will be assessed with inelsatic tape
fasting blood glucosesIt will be assessed after 12 weeksit will be assessed in plasma
systolic blood presssureIt will be assessed after 12 weeksit will be assessed at brachial artery
diastolci blood pressureIt will be assessed after 12 weeksit will be assessed at brachial artery
subjective vitality scaleIt will be assessed after 12 weeksA questionaire will assess vitality of subjects
satifaction with life scaleIt will be assessed after 12 weeksA questionsire will assess satisfaction with life
ptisburg sleep quality indexIt will be assessed after 12 weeksA questionsire will assess sleep level
fatigue severity scaleIt will be assessed after 12 weeksA questionsire will assess fatigue level
Behcet disease -related life quality questionaireIt will be assessed after 12 weeksA questionsire will assess life quality
ruffier indexIt will be assessed after 12 weeksit will assess fitness of cardiopulmoanry system
Hamilton anxiety rating scaleIt will be assessed after 12 weeksA questionsire will assess anxiety
Hamilton depression scaleIt will be assessed after 12 weeksA questionsire will assess depression

Countries

Egypt

Contacts

CONTACTAli Ismail, lecturer
ali.mohamed@pt.cu.edu.eg+201005154209
CONTACTAli mohamed, lecturer
fatmaraed1994@gmail.com+201033321109
PRINCIPAL_INVESTIGATORAli MA Ismail, lecturer

Cairo University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 15, 2026